跳至主要内容
临床试验/NL-OMON41161
NL-OMON41161已完成不适用

The immunomodulatory effects of phlebotomy - The immunomodulatory effects of phlebotomy

niversitair Medisch Centrum Sint Radboud0 个研究点目标入组 10 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
10

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • - Age >18 and <36 years
  • - Healthy as concluded from medical history

排除标准

  • - Having donated blood to the blood bank within one year preceding phlebotomy
  • - Significant blood loss from trauma within one year preceding phlebotomy
  • - Having lost > 100 ml of blood due to any cause, within 3 months preceding phlebotomy (not counting blood withdrawn during screening visit)
  • - Having lost > 50 ml of blood due to any cause, within 1 month preceding phlebotomy (not counting blood withdrawn during screening visit)
  • - Having lost >20 ml blood due to any cause, within 1 week preceding phlebotomy
  • (not counting blood withdrawn during screening visit)
  • - Family history of thallasemia, sickle cell disease, hereditary hemochromatosis, or iron refractory iron deficiency anemia
  • - Signs of history of infection within 2 weeks preceding phlebotomy
  • - History of frequent vasovagal response

研究者

发起方
niversitair Medisch Centrum Sint Radboud

相似试验